Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important steps before the introduction of new antimalarials.